Future of Money Governance & the Law New Podcast Host

Washington, DC, Oct 11, 2022 – (ACN Newswire) – The Government Blockchain Association (GBA) announces that Ms. Jacqueline Cooper has been named the new host for 'The Future of Money Governance & the Law' podcast.



Ms. Cooper's background is a Who's Who of success, therefore, GBA has decided to interview her.

GBA: What news or secrets are you hoping to uncover with this podcast?
JC: Our blockchain community is huge, and GBA has a diverse membership. I hope those being interviewed will share behind-the-scenes knowledge of upcoming trends in the technology, legislation, and use applications.

GBA: What are some of the biggest challenges facing the adoption of blockchain right now?
JC: Ignorance is one of the biggest challenges facing blockchain adoption. That, and media feeding the glamour and celebrity hype. Additionally, there are differing philosophies of decentralized versus centralized, challenging the economic structure within the global community of financial markets.

GBA: Where do you predict blockchain is headed?
JC: Blockchain is a tool that will be integrated into document collection, identity protection, finances, healthcare, and more. The friction experienced in cross communication between different blockchains will be resolved. Just like cars traveling from one highway to another, we will be able to transfer information across blockchain platforms around the world with privacy and speed.

GBA: Who would you most like to interview and why?
JC: GBA members that are blockchain notables, and "thought leaders," as well as individuals who don't believe they are making an impact but truly are. Also, individuals from different countries, to discuss how blockchain is benefiting their citizens. Finally, I would love to interview Governors, Mayors, and legislators to discuss how blockchain can support elections, commerce, and careers.

GBA: How will blockchain tech impact the common citizen?
JC: In finances, health, education, art, music, and commerce, the common citizen will enjoy the developments created by blockchain. I am excited to be part of this journey and sharing the story as it develops.

Be sure to catch Jacqueline on GBA's 'The Future of Money, Governance, & the Law' https://gbaglobal.org/podcast expose how blockchain is disrupting the world through technology.

The Government Blockchain Association (GBA), www.gbablobal.org is a non-profit, business-league organization, helping the public and private sectors connect, communicate, and collaborate over everything blockchain.

To book a complimentary blockchain consultation with Ms. Cooper, Email cryptomom2consulting@gmail.com.

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

analytica Vietnam exhibition returns to reunite the industry after its 4 years hiatus

HO CHI MINH CITY, VIETNAM, Oct 11, 2022 – (ACN Newswire) – analytica Vietnam announces its return on 19-21 April 2023 to reunite the diagnostics laboratory industry in Southeast Asia after 4 years. It is part of the world's leading series of analytica exhibitions which is headlined by the world's largest show for this sector in Munich. The upcoming seventh edition of the trade fair for analysis, laboratory technology and biotechnology will be held at the Saigon Exhibition and Convention Center (SECC) in Ho Chi Minh City, Vietnam. Since its launch in 2009, analytica Vietnam has become the industry's most vital trade fair in the growing laboratory market in SEA. 2023 will be the first largest face-to-face reunion of the industry to resume its extensive conference program alongside supporting side events to accompany the exhibition. Companies who wish to exhibit can begin registration now for analytica Vietnam and rejoin industry experts – Analytik Jena, Merck, Metrohm, Mettler Toledo, Shimadzu and Water — at the exhibition next spring.

The largely expanding Vietnamese market for analysis, biotechnology and laboratory technology is displayed by the high demand for exhibiting opportunities at analytica Vietnam. In 2019, the trade fair recorded 143 exhibitors spanning 15 countries and more than 4,144 registered trade visitors, marking a rise of 33% in occupied space from its previous edition in 2017. Returning from the pandemic, this event will once again provide its featured exhibitors and trade visitors with a platform to push the exposure of their businesses and networks to new heights.

Re-penetrating Southeast Asia's fastest-growing market
Vietnam`s economy is increasing rapidly; with an expected real GDP growth of 5.5%-6.5% this past year. Vietnam's GDP forecast is positive and better than the other ASEAN countries in 2022 with a projected growth of 6.7% in 2023. With that growth rate, Vietnam stands to be one of the most dynamic counties in Southeast Asia where its main growth driver is the processing industry, which grew by an impressive 11% even during the pandemic. The dynamic strength of the economy is also reflected in the great business potential in analytics, laboratory technology and biotech industries which analytica Vietnam will be bringing together.

Face-to-face networking with old and new connections
As the leading exhibition in its sector and the largest trade fair in the analysis, laboratory technology and biotechnology markets, attendees will be exposed to new potential customers from untapped markets at a level they have not experienced in years. The exhibition is also supported by leading institutions, and renowned associations and boasts a myriad of international pavilions including China, Germany, Taiwan and Singapore. Reports from previous editions showed that 98% of visitors would recommend the exhibition to their networks, 93% would attend the upcoming edition and 97% are satisfied with the completeness and breadth of the product range showcased at the trade fair. Exhibitors are also invited to join the offsite lab tours for some valuable insights into a local Vietnamese lab.

"analytica Vietnam's comeback is set to be the most exciting trade fair for this sector Southeast Asia has yet to expect," says Michael Wilton, CEO of the trade-fair organizer, MMI Asia Pte Ltd. "I'm excited to witness the reunion of the industry, showcases of new technology and shared knowledge through new and old connections happening again after the world's recovery from COVID-19," Michael affirms. Therefore, in 2023, analytica Vietnam will once more integrate the valuable experience of new meetings and the passing of new solutions through a holistic platform.

Further information on analytica Vietnam and registration documents can be found at www.analyticavietnam.com.

analytica Vietnam

With its exhibition areas of laboratory technology, analysis, biotechnology and diagnostics, analytica Vietnam with the analytica Vietnam conference targets the growing market of Vietnam. 143 exhibitors and 4,144 visitors participated in analytica Vietnam 2019. The trade fair takes place every two years. The upcoming edition will take place from April 19 to 21, 2023 at the SECC – Saigon Exhibition and Convention Center www.analyticavietnam.com.

analytica worldwide

Messe Munchen is the world's leading trade fair organizer for laboratory technology, analysis and biotechnology. The international network of exhibitions includes analytica, analytica China, analytica Anacon India & India Lab Expo, analytica Vietnam and analytica Lab Africa. Additional information about these exhibitions and their programs of events is available at www.analytica.de.

MMI Asia Pte Ltd

MMI Asia Pte. Ltd. was set up as the regional headquarter and a wholly owned subsidiary of Messe Munchen in 1992. With subsidiaries in China and India, MMI Asia organizes trade fairs in China, India and ASEAN countries; promotes global trade expansion by facilitating participation of Asian exhibitors in Messe Munchen fairs worldwide; it also provides consultancy in professional trade fair and conference management to government bodies, international trade and promotion organizations, and trade associations.

Messe Munchen

Messe Munchen is one of the leading exhibition organizers worldwide with more than 50 of its own trade shows for capital goods, consumer goods and new technologies. Every year, a total of over 50,000 exhibitors and around three million visitors take part in more than 200 events at the exhibition centre in Munich, at the ICM – Internationales Congress Center Munchen and the MOC Veranstaltungscenter Munchen as well as abroad. Together with its subsidiary companies, Messe Munchen organizes trade shows in China, India, Brazil, Turkey, South Africaand Vietnam. With a network of associated companies in Europe, Asia, Africa and South America as well as around 70 representatives abroad from over 100 countries, Messe Munchen has a global presence.

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Indonesia Market Poised for Big Growth in Streaming

JAKARTA, Oct 11, 2022 – (ACN Newswire) – For the first time in three years the Asia Video Industry Association (AVIA) returned to Jakarta to host Indonesia in View 2022, an event that welcomed some of the industry's biggest players for a day of discussions dissecting the opportunities for growth in this expansive market.

Opening comments were made by Yuliandre Darwis, Commissioner with the Indonesian Broadcasting Commission (KPI) who talked about the development of the KPI over the last twenty years, and the hope for revisions to the broadcasting law which could see greater responsibilities given to them.

Highlights of the Indonesia in View Report, to be published by AVIA, were given by Bettina Cavenagh, President Director, Clarity Research Indonesia, outlining the state of Indonesia's video markets in the post-pandemic economy. Pay television had plateaued and while DTH services were the biggest victims of increased broadband penetration, cable numbers were increasing meaning the overall pay TV market remained significant, even if ARPU's were under pressure. But all eyes were now on the premium OTT market. Subscription Video on Demand (SVOD) has grown by more than 50% from 2020 to 2021, to 11.5M subscribers, while digital advertising grew by 33% over the same period. This set the scene for much debate throughout the conference on the relative merits of the subscription versus the advertising led business model for OTT.

In a conversation around growth and monetization, Hermawan Sutanto, COO of Vidio talked of the need to educate the market to pay for premium OTT services and Guntur Siboro, Country Head for Lionsgate Play further made the point that ad supported VOD (AVOD) was a different ballgame which required significant investment to monetise successfully. Whatever the business model, Avijit Duta, Deputy Country Manager for Viu, emphasized the need for the business to be sustainable and everyone was witnessing rising production costs as the production talent pool was still limited today.

In his keynote conversation, Sutanto Hartono, Managing Director of EMTEK and CEO of SCM and Vidio, discussed Vidio's emphasis on local originals and live sports as differentiators in their quest to acquire customers and keep churn down. While sports rights were expensive and not owned in perpetuity, they played a crucial role in a growth strategy. Marlo Budiman, CEO & President Director, Link Net, later added that while the pay TV market had plateaued, its death knell had not quite sounded yet and also attributed this to the role of sports and original content keeping OTT churn low.

Clarissa Tanoesoedibjo, Managing Director of MNC's Vision+, also talked about the importance of local original content and that Vision+ was increasing their investment in this sector for the service. She also pointed out that while Vision+ was primarily subscription led, the accompanying RCTI+ service was advertising led.

There was little doubt about the importance advertising played in the growth prospects for the market when Gavin Buxton, Managing Director, Asia for Magnite, Florencia Eka, Country Manager, Client Services, for The Trade Desk, and Lesley Simpson, Country Manager for WeTV and iflix Indonesia, got together. They agreed that OTT was the natural evolution of TV and provided unique opportunities for digital advertisers given the engagement with viewers. And while fragmentation of services was an issue, it was clear that there was more than enough scale in premium OTT as they looked forward to sustained growth in the sector.

Indonesia in View is generously sponsored by Gold Sponsors A+E Networks, Vidio and Vision+ and Silver Sponsors Akamai, Broadpeak, CDNetworks, Conviva, INVIDI, Irdeto, NAGRA, SES, TV5MONDE and YouTube.

About the Asia Video Industry Association

The Asia Video Industry Association (AVIA) is the trade association for the video industry and satellite ecosystem in Asia Pacific. It serves to make the video industry stronger and healthier through promoting the common interests of its members. The AVIA is the interlocutor for these industries with governments across the region, leads the fight against video piracy through its Coalition Against Piracy (CAP) and provides insight into the video industry through reports and conferences aimed to support a vibrant video industry.

For media enquiries and additional background, contact:
Charmaine Kwan
Head of Marketing and Communications
Email: charmaine@avia.org
Website: www.avia.org
LinkedIn: www.linkedin.com/company/asiavideoia
Twitter: @AsiaVideoIA

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Let’s Roll! Dallas Startup is Revolutionizing the Music Industry

DALLAS, TX, Oct 11, 2022 – (ACN Newswire) – Rock 'n roll may be dead, but the music business is still projected to grow to $142 billion by 2030 globally, according to Goldman Sachs. Despite this growth the average musician is consistently being squeezed by the big players and not earning their fair share of the value of the art they have created. Community Musician — originally a "Craig's List" for musicians — has developed a plan and formed a team to disrupt this unbalanced monopolistic system, all while ensuring that the musicians they work with are properly compensated for their talents.




Scott Arey, the CEO of Community Musician who is also the front man and songwriter for his latest band The Lost Cavaliers of Mercy, understands the struggles of the average musician in the cutthroat industry. As a young musician, Arey signed with Warner Music and began touring as a warm-up act for the Indigo Girls, but he quickly discovered he couldn't make enough money to pay his bills.

"I would max out my credit cards just trying to pay the expenses of putting together a few cities' tour, never mind trying to pay the band," Arey reminisces.

Partly due to the economic hardships he faced as a musician, Arey decided to pivot to a business career. After graduating from Stanford University, he began his career with KPMG and soon joined Bank of America where he worked for ten years, eventually becoming CFO of the Commercial Banking Division and then CFO of BofA's International Trade Bank. He then led a series of successful start-ups to growth and investor exits, such as Journey, Alsbridge, Gearbox and even a publicly traded microcap company he got NASDAQ to agree to list on their exchange.

Whether or not Arey has the ability to lead Community Musician in a way that forever alters the landscape of the music industry could be a billion-dollar question. Just before his current run of with Community Musician, Arey took a company valued at $66 million when he joined to a $1.3 billion exit in less than three years. Arey won't be alone leading the company, as he is partnering with Community Musician President Derek Toone who has also driven hundreds of millions of dollars in shareholder value — most recently at Automation Anywhere, which in 2018 had the highest Series A valuation at $1.8 billion in Silicon Valley history.

Arey believes that he has the resources and the personnel to take Community Musician to the next level.

"Derek Toone and I have individually and collectively applied sound business practices to the enterprises we've made successful, enterprises that frankly, were resistant to doing so. We are uniting musicians in common cause to pool resources and apply those resources wisely and effectively to meet the challenges all musicians face," says Arey.

While the road ahead will be a long one, Community Musician plans the start of its journey with an acquisition of Puddletown Rehearsal Studios based in Portland, Oregon, which currently has 8 buildings and 350 rooms serving a community of over 8,000 local musicians. Community Musician plans to further develop its already successful app for musicians and its patented Collectible Music Card which uses the same NFC chip that trigger high fidelity (i.e., lossless vinyl quality) recordings to play on any smartphone, with just a tap.

Nic Yannariello, who toured with bands like Tool, Filter and Rage Against the Machine, created Puddletown after he built and sold the now-iconic venue the Hawthorne Theatre. Yannariello has joined Community Musician as SVP of Operations and will run the nationwide music rehearsal studio business.

"If you're a serious musician, you either have a rehearsal space, you're sharing with someone, or trying to get off the waiting list for a space," Yannariello said. "Either way it all starts with rehearsal."

Yannariello is chopping at the bit. "You wanna rock? Then let's roll, we've got tools, we've got the talent, jump in, the water's just fine."

Web: https://communitymusician.com/
Apple App Store: https://apps.apple.com/us/app/community-musician/id1584215306
Google Play Store: https://play.google.com/store/apps/details?id=com.cm.commuscian
Source: Plato Data Intelligence: https://platodata.io

Contact Info:
Name: Bryan Feinberg
E-mail: zephyr@platodata.io
Organization: Plato Data Intelligence
Address: 144 E44th St, New York, New York 10017, United States
Website: https://Platodata.io

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

ClinicalSquared Partners with Solve.Care to Create Web3 Health Networks on the Blockchain

Washington, D.C., Oct 11, 2022 – (ACN Newswire) – Solve.Care (https://solve.care/), a healthcare platform company that leverages blockchain to deliver better care and ClinicalSquared (www.clinicalsquared.com), a multi-disciplinary technology consulting company specializing in custom software development, today announced that they have joined forces to create Web3 health networks on the Solve.Care Platform. The announcement was made at the Blockchain & Infrastructure Conference held at the National Press Club in Washington DC, and organized by the Government Blockchain Association.



The decentralized Care.Platform from Solve.Care allows for the quick creation and deployment of interoperable health networks. Governments, businesses and even individuals can author their own networks using the Care.Labs low-code development portal.

Digital health networks on the Care.Platform are known as Care.Networks. Data in Care.Networks are stored on decentralized nodes, where all interactions and transactions are automatically tokenized. They can be authored without the need for any Web3 or blockchain knowledge. Care.Network owners can also opt to outsource the authoring of their Care.Networks to any third party or utilize ClinicalSquared, having been appointed as the official authoring agent of Care.Platform.

Pradeep Goel, CEO of Solve.Care said, "Having ClinicalSquared on board, enables for our clients to have their Care.Networks rolled out to the market at an even quicker timeframe. While our clients are in the best position to know when they want from their Care.Networks, they may not always have the capacity to author them. It is about giving our clients options that best serve their interests."

Marquis Allen, CEO of ClinicalSquared said, "We are excited to partner with the Solve.Care team, leveraging our skills, technical resources, and formidable experience in the healthcare IT sector to accelerate the development of blockchain-featured healthcare solutions. We welcome the opportunity to serve."

Both ClinicalSquared and Solve.Care are members of the Government Blockchain Association (GBA) (https://gbaglobal.org/). The GBA is an association that connects people and organizations with blockchain technology-based solutions to problems typically faced by government entities.

Source: Platodata Intelligence https://platodata.io

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Dr. HOOY Kok Wai, Chairman of the Board of China Wantian Holdings, wins the 17th World Outstanding Chinese Award; Mr. ZHONG Xueyong, Chief Executive Officer and Executive Director of China Wantian Holdings, is honoured with the 3rd World Outstanding Chinese Youth Entrepreneur Award

HONG KONG, Oct 10, 2022 – (ACN Newswire) – "Take practical action in a down-to-earth manner and aim high to achieve growth" is the long-standing company philosophy of China Wantian Holdings Limited ("China Wantian Holdings", together with its subsidiaries, the "Group"; Stock Code: 1854.HK). As a green enterprise engaged mainly in environmental protection and technology, retail, catering and fresh food supply, China Wantian Holdings has actively supported China's Greater Bay Area (GBA) development plan and net-zero carbon emissions vision in recent years, while outlining its development path for the GBA and striving to become one of the region's leading green brands. At a prize-giving ceremony yesterday, Dr. HOOY Kok Wai, Founding President of Guangdong – Hong Kong – Macau Greater Bay Area Industry and Commerce Federation, Vice Chairman of Perfect (China) and Chairman of the Board of China Wantian Holdings, was honoured with the 17th World Outstanding Chinese Award. Mr. ZHONG Xueyong, Founding Chairman of Guangdong – Hong Kong – Macau Greater Bay Area Industry and Commerce Federation, Co-Chairman of Wangu Group and Chief Executive Officer and Executive Director of China Wantian Holdings, was presented with the 3rd World Outstanding Chinese Youth Entrepreneur Award. Dr. HOOY Kok Wai and Mr. ZHONG Xueyong received the awards in recognition of their outstanding performance and achievements in the industry, and their active participation in public welfare affairs over the years, contributing to the social economy and helping to improve people's lives.


Dr. HOOY Kok Wai, Chairman of the Board of China Wantian Holdings, was presented with the 17th World Outstanding Chinese Award.

Mr. ZHONG Xueyong, Chief Executive Officer and Executive Director of China Wantian Holdings, was presented with the 3rd World Outstanding Chinese Youth Entrepreneur Award.

Dr. HOOY Kok Wai (left), Chairman of the Board of China Wantian Holdings, took photo after receiving Lincoln University's honorary doctorate degree.


As a Chairman of the Board at China Wantian Holdings and Vice-chairman of Perfect (China) Co., Ltd., Dr. HOOY Kok Wai brings to bear more than 30 years' deep experience of management and business development. He is also a renowned Chinese entrepreneur who focuses on improving people's lives. Dr. HOOY Kok Wai started his business in 1980. He was invited by his close friend Mr. Koo Yuen Kim, a third-generation member of the Chinese-Malaysian community, to visit Zhongshan, in Guangdong Province, where they co-founded Perfect Commodity Co., Ltd. ("Perfect Co.") in 1993. Over the years, Perfect Co. has continued to grow and has become a modern enterprise engaging in scientific research, production, sales and services. Making cumulative tax contribution of around RMB38.8 billion, Perfect Co. has become the largest taxpayer in Zhongshan. Adhering to a lifelong philosophy of positivity, optimism and hard work, Dr. HOOY Kok Wai contemplated starting a second business, and joined forces with Mr. ZHONG Xueyong to lead China Wantian Holdings, developing it as an enterprise that safeguards people's food safety and promotes the urban economy to fulfil the promise of helping people live better lives. In recent years, China Wantian Holdings has actively responded to China's call to improve people's health, embracing green development and adopting a mission to enable thousands of families to eat well every day, and it has worked tirelessly to become a leading lifestyle service provider in China.

Mr. ZHONG Xueyong, the Group's Chief Executive Officer, is a post-1980s generation young entrepreneur, community leader and philanthropist. Mustering a Hakka spirit of diligence, innovation and pragmatism, Mr. ZHONG Xueyong founded Wangu Group in 2012 and accumulated the means to contribute to society through developing his business. In 2015, Mr. ZHONG Xueyong established Wangu Shopping Basket Plaza, a landmark project with both exterior and inner functions, making a commitment to developing it as a five-star safe food market providing air and water purification and one of the Zhongshan government's major large-scale livelihood projects. In 2018, with Dr. HOOY Kok Wai, Mr. ZHONG Xueyong founded WG Sky Farm International Group, which develops the rooftops of schools, government offices, hospitals and factories to create distinctive sky farm and grow organic vegetables, advancing healthy lifestyles, environmental protection and afforestation. In addition to setting an example for a new generation of entrepreneurs, Mr. ZHONG Xueyong never forgets his origins and always remembers past kindnesses he has received. He endeavours ceaselessly to contribute to society, helping disadvantaged members of the community and actively participating in the promotion of public welfare. As of 2021, he had organized more than 100 public welfare activities and had donated tens of millions renminbi to the disadvantaged group, directly benefiting over 100,000 people.

The honours of the World Outstanding Chinese Award and the World Outstanding Chinese Youth Entrepreneur Award recognise the business philosophies and social influence of Dr. HOOY Kok Wai and Mr. ZHONG Xueyong over the years, during which they have distinguished themselves through their kindness and by cultivating a strong sense of social responsibility among China Wantian Holdings' management. "For being well prepared and raring to go, god rewards those who work hard," is Dr. HOOY Kok Wai's motto. As management at the Group, Dr. HOOY Kok Wai believes that he must set a good example for his employees. He remains ever-mindful of his origins, he always returns expressions of kindness he has been shown, and he devotes himself tirelessly to helping others succeed. He also strives to achieve further breakthroughs and surpass himself in corporate development. Mr. ZHONG Xueyong says it is his aspiration to contribute to livelihoods nationwide through entrepreneurship. To make an even greater contribution to society, he aspires to supply the Chinese people with the highest-quality food ingredients by continuously upgrading and expanding China Wantian Holdings' business.

Driven by its mission of enabling thousands of families to eat well every day, China Wantian Holdings is committed to becoming a leading lifestyle service provider in China. Leveraging its two leaders' solid experience of business operations and strong social networks in China, the Group will actively cooperate with the Chinese government in developing a philosophy of modern agriculture technology and green environmental protection by creating fertile land on unused rooftop spaces to increase the proportion of urban greenery. The Group will promote environmental education at enterprises and in schools in order to support the sustainable development of the GBA. In the future, leveraging the honours received by Dr. HOOY Kok Wai and Mr. ZHONG Xueyong, China Wantian Holdings will proactively establish a development path for the GBA in line with China's national development plan and net-zero carbon emissions target, with the aim of becoming a leading green enterprise brand in the region.

The 3rd Guangdong-Hong Kong-Macao Greater Bay Area Outstanding Young Entrepreneur Award Ceremony, co-organized and sponsored by China Wantian Holdings, was held simultaneously in Hong Kong, Macau and Shenzhen on 21 September 2022. One-hundred-and-two winners were selected from fields including semiconductors, autonomous driving, healthcare, home economics and the Internet of Things, based on their contributions and outstanding achievements in the GBA. The event was designated by the Government of the Hong Kong Special Administrative Region as one of the activities to celebrate the 25th anniversary of the city's returning to Chinese sovereignty. Mr. John Lee, Hong Kong Special Administrative Region's Chief Executive, attended and delivered a speech at the ceremony. At the event, Mr. ZHONG Xueyong was invited to shake hands and have his photograph taken with Mr. Lee.

The award aims to identify the highest-potential and most representative young entrepreneurs in the GBA and recognise their outstanding contributions to promoting the integrated development of the region. It is hoped that more young talents will be encouraged by the two China Wantian Holdings entrepreneurs' success at the awards and seize opportunities to engage with the development of the GBA. China Wantian Holdings is actively engaged in the development of the GBA, and is committed to becoming a leading green brand in the region to contribute more to its economy and exquisite lifestyle in the society. The Group's management also hopes that young talents will pursue the opportunities the GBA offers and help the region to excel in harmony with the philosophy of the Guangdong-Hong Kong-Macao Greater Bay Area Outstanding Young Entrepreneur Award Ceremony.

About China Wantian Holdings Limited
China Wantian Holdings (1854.HK) is an investment holding company. The Group is principally engaged in sourcing, processing and supplying food ingredients, with a focus on the provision of vegetables and fruit to food service operators in Hong Kong. It supplies in excess of 1,300 food ingredients to more than 480 customers. In May 2022, China Wantian Holdings established its Greater Bay Area headquarters in Shenzhen, marking its official debut in the Greater Bay Area market. The Group will focus on developing three main businesses in this market, including fresh food supply, retail and catering, as well as environmental protection and technology and actively establish a leading green brand in the Greater Bay Area to provide customers with fresh, healthy and safe food.

For more details, please visit: chinawantian.etnet.com.hk


Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

1,450+ Organisation Identified in the UAE Web3 Space as per the Crypto Oasis Ecosystem Report 2022

DUBAI, Oct 10, 2022 – (ACN Newswire) – Crypto Oasis, the fastest growing Web3 ecosystem in the world, announced that it had identified more than 1,450 active Web3 organisations in the UAE at the end Q3 2022. The research also identified more than 7,000 individuals working in the industry.

The organisations that are active in the Blockchain space are broken down into native and non-native according to their dependency on this emerging technology. native organisations which only exist because of this technology account for 65 percent of the total number identified and non-native organisations are at 35 percent. Dubai Multi Commodities Centre(DMCC) has registered more than 460 native organisations which is more than 50% of all native Blockchain organisations in Dubai.

Out of the 7,000+ individuals working in the Web3 industry, approximately 77 percent work in Blockchain native organisations and 23 percent work in non-native organisations.

The Crypto Oasis Ecosystem Report is a periodic report which is now on its inaugural edition and was created in partnership with Roland Berger, one of the first top-tier strategy consulting firms to have entered the world of Blockchain and is steering their global Crypto Economy advisory out of the UAE. The Report focuses on market development and emerging technologies such as Crypto, Blockchain, Metaverse and Web3. It establishes the first quantitative and qualitative ecosystem study of the Crypto Oasis Ecosystem and identifies its various stakeholders. It includes, a deepdive into the opportunity that Web3 represents for the region, has exclusive content such as the insights on one the largest greenfield mining sites in the world being carried out by Phoenix in Abu Dhabi, as well as survey results by Roland Berger, that assesses the state of the global Crypto Economy for which they collected insights from over 150 C-level executives and innovators across 10 industries. "We strongly believe in the transition towards a crypto economy and see this reflected in the top C-Level executive agendas. The UAE is accelerating its global position as a Crypto and Web3 hub, also thanks to prime ecosystem developers like Crypto Oasis," says Pierre Samaties, Partner and global co-head of the firm's Crypto economy team.

The UAE is uniquely positioned to play a leading role in the global innovation economy. The growth of the Crypto Oasis Ecosystem will continue in the coming months as we can already witness how regulators in the region are welcoming innovation and disruption, making it simpler for Blockchain-related companies to secure licenses and operate. Ralf Glabischnig, Founder of the Crypto Oasis said, "We are pleased to see the UAE supporting forward-thinking organisations such as startups, service providers, investors, as well as science and research institutions in the Web3 space. We also have industry leading stakeholders like ADGM, DIFC, DMCC, Simmons and Simmons, State Street featured in our report which will provide the audience with a deeper insight into industry trends as well as educate and inform the reader of this ever growing and evolving ecosystem. Through the report, you are provided with a snapshot of the Ecosystem, which will help set the baseline from which growth can be identified in the following years as the Crypto Oasis becomes a centre of Blockchain excellence."

Crypto Oasis catalyses the growth of organisations in the Crypto space and brings together Investors, Start-ups, Corporates, Researchers, Service Provider, and Government entities. It aims to advance the digital economy in the Middle East and bring distributed ledger technologies to the mainstream. Faisal Zaidi, Co-founder and CMO of the Crypto Oasis stated, "Our role is to curate the Crypto Oasis Ecosystem and our goal is to bring all stakeholders together on one playing field to assert the region as the leading global player in Web3."

He added, "The Crypto Oasis Directory and the parallely launched report, are tools that we have developed and created inhouse and published, in order to create transparency and awareness of this emerging region."

The report also contains insightful thought leadership articles from major players in the industry like 4ARTechnologies, Pulse, Ripple, Securrency, Singularity DAO, TDEFI, Tokengate, Virtua to name a few.

Report Link: https://cryptooasis.ae/ecosystem-report-2022/
Directory Link: https://cryptooasis.ae/directory/

About Crypto Oasis

The Crypto Oasis is a Middle East focused Blockchain Ecosystem supported by initiators of Crypto Valley Switzerland. The core elements needed for its growth are Talent, Capital, and Infrastructure. The Ecosystems stakeholders include Investors & Collectors, Start-Ups & Projects, Corporates, Science & Research Institutions, Service Providers and Government Entities & Associations. Crypto Oasis' vision is to be one of the leading Blockchain Ecosystems in the world. Today it is the fastest growing, with more than 1,450 organisations identified in the UAE alone. www.cryptooasis.ae

About Roland Berger

Roland Berger is the only management consultancy of European heritage with a strong international footprint. As an independent firm, solely owned by our partners, we operate 51 offices in all major markets. Our 2,700 employees offer a unique combination of an analytical approach and an empathic attitude. Driven by our values of entrepreneurship, excellence and empathy, we at Roland Berger are convinced that the world needs a new sustainable paradigm that takes the entire value cycle into account. Working in cross-competence teams across all relevant industries and business functions, we provide the best expertise to meet the profound challenges of today and tomorrow. www.rolandberger.com

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

The 18th edition of World Cloud Show presented an incisive analysis of Cloud and Data Centers in India.

MUMBAI, INDIA, Oct 10, 2022 – (ACN Newswire) – Co-powered by Lightstorm, and supported by NITI Aayog, the 18th edition of the World Cloud Show – India concluded after a day filled with understanding of the next phase of cloud transformation and data centers in India.



The India edition of World Cloud Show catalyzed the development of the Indian government's Cloud Vision, shedding light on several initiatives for the development of Cloud Computing and Data Centers in India, as well as the economic contribution that organizations supporting cloud computing are making to the country. Government officials, tech sector titans, and a stellar lineup of over 25 esteemed speakers from top international organizations were present at this event to provide their insightful feedback.

The conference's main themes were adapting to the new normal and managing the upcoming Cloud and Data Centers transformation. It presented divergent perspectives from a diversified industry by exchanging ideas, addressing significant learning, and emphasizing recent advancements from the corporate, government, and professional sectors.

Some of the top speakers who took the center stage included:
– Suresh Sankaranarayanan; Senior EVP & CTO, Kotak General Insurance
– Nikunj Jain; CIO & Digital Leader, P&G India
– Ekhlaque Bari; CIO Jubilant Food Works
– Dr Avadhut Parab; Chief Information Officer, Parle Agro
– Sourav Das; Chief Digital & Information Officer, Essel Mining – Aditya Birla Group
– Viral Davde; Chief Technology Officer, NCDEX
– Ananth Kumar; Engineering Leader, Site24x7
– Vinod Kumar; EVP & Chief Information Officer, Fino Payments Bank
– Ninad Raje; Director & Chief Information Officer, Health Assure
– Amajit Gupta; CEO, Lightstorm
– Vamsi Krishna Ithamraju; Chief Technology Officer, Axis Mutual fund
– Abhishek Sukhwal; Head Cloud Center of Excellence, Mahindra & Mahindra Ltd.
– Rajgopal Nayak; Chief Technology Officer, Metro Brands
– Ashish Sharma; Strategy Head Special Projects, Web Werks
– Roberto Frongia; Strategy & Operations Director Technology and Digital Compute & Innovation NEOM UAE
– Suresh Chandrasekaran; Executive Vice President, Denodo
– Manish Kishore; Global CIO Wockhardt ltd
– Nasreen Khan; Head – Cloud & Cloud Security, Bharat Petroleum Corporation Ltd.

Ninad Raje, Director & CIO, Health Assure, remarks, "If cloud technology is the soil, then Data Centers are the pipeline that supplies the water to the soil." While shedding light on the exponential expansion of the data center market at the World Cloud Show – India, Ninad added, "In the Indian market, Data Centers are unquestionably here to stay and are committed to the long term."

Dr Avadhut Parab, CIO, Parle Agro, offered significant insights on the application of AI and ML, "Machine learning and artificial intelligence are no longer myths. The improvement of customer service and experience through data augmentation based on customer feedback increases brand recognition. IT and business operations are now run much more efficiently, thanks to AI and ML."

Suresh Chandrasekaran, Executive Vice President, Denodo, took part in a panel discussion and listed top three takeaways from the current environment in the data center industry, and said, "Before collecting data, organizations must continually connect the data. Data literacy and unified data control are required for every organization, as is the decoupling of business transformation and IT operations."

The various cloud models and services enabling enterprises to implement the cloud in different ways and effectively invest in technology were one of the major topics of discussion at the event. The speakers on this panel included Suresh Sankaranarayanan, Senior EVP & CTO, Kotak General Insurance; Nikunj Jain, CIO & Digital Leader, P&G India; Prasanna C, Head of Product & Marketing, Lightstorm; and Manish Kishore, Global CIO, Wockhardt Ltd.

In this panel discussion, panellists talked about the best cloud migration approaches for companies in a variety of industries. The panel also discussed heavily on the value proposition of Kubernetes in the modern workspace and edge computing.

Another notable panel discussion during the event covered the topic of "Data Centers Reimagined: AI, ML, Edge & Virtualization". The panel examined cutting-edge data center technology and how organizations can use it to maximize the value of their data. The speakers of the panel included Dr Avadhut Parad, CIO, and Parle Agro; Sourav Das, CIDO, Aditya Birla Group. Viral Davde, CTO, NCDEX; Vinod Kumar, EVP & CIO, Fino Payments Bank.
The panel talked about the rapid expansion of ML and AI in the Indian market. Panellists gave insights on the various tools used for the functioning of Data Centers, whilst also shedding light on the role of edge in sustainability initiatives.

Large enterprises have diversified business functions, converged technologies have given enterprises the scalability while significantly reducing time to market," quoted Sourav Das, CIDO, Aditya Birla Group as he shared his thoughts on converged technologies at Trescon's World Cloud Show – India.

Lightstorm's Amajit Gupta gave a comprehensive presentation on the theme of powering the inevitable network. He emphasized how important it is for a network to be able to adapt to the rapidly changing environment in which we live. For organizations to succeed, modern networks and the speed at which information is sent to them are essential. "Every business owner wants to be at the vanguard of a digital revolution," stated Mr Amajit Gupta, CEO of Lightstorm, while discussing new technological developments at Trescon's World Cloud Show. He added, "It is a logical progression given that businesses can now sell everywhere thanks to cloud technologies. Instead of increasing their physical footprint, businesses will concentrate on growing their digital footprint."

Ananth Kumar, Engineering Leader, Site24x7 gave another very impactful presentation to the audience about choosing a monitoring system and various factors to consider. He highlighted the distinctions between on-prem and SaaS solutions by emphasizing the business's cost, time, skill, and requirements.

Basil Dhange, CISO of Aditya Birla Sun Life AMC Ltd., shared his top tips for moving to the cloud, and quoted, "It is critical to identify pain-points of on-premise before migrating to the cloud, also very important to understand your data and then embark on your cloud journey."

"We need to switch from a smart approach to one that is more holistic and cognitive. We are looking for innovation in every corner of the world. The Indian market is highly valued by NEOM and we intend to utilize it to advance our endeavour to accelerate human progress," said Roberto Frongia, Strategy & Operations Director Technology and Digital Compute & Innovation NEOM UAE.

Presenting the hybrid cloud platform of Web Werks, which scales with the expansion of businesses was Ashish Kumar, Strategy Head of Projects at Web Werks. Among the subjects covered by Mr Ashish Sharma were the data fabric, contemporary data management technologies and integration, and augmented or automated data management. A thorough presentation that addressed all the concerns and questions that several decision-makers had.
Nasreen Khan, Head of Cloud & Cloud Security, Bharat Petroleum Corporation Ltd., commented as she moderated the panel discussion on cloud security, and said, "Cloud has a huge range. Like the weather, it is a dynamic environment that changes. As soon as your company makes the major switch to the cloud, I suggest doing routine data audits."

The 18th global edition of World Cloud Show is officially sponsored by:
– Supported By: NITI Aayog
– Co-Powered By: Lightstorm
– Gold Partner: Site24x7 & Web Werks
– Silver Partner: Denodo

About Cloud Show

World Cloud Show is a global series of events that take place in cities all over the world and are focused on business and thought leadership.

The Indian edition of the world tour will bring together qualified CIOs, CTOs, COOs, Heads of Cloud, Heads of IT Infrastructure, Heads of Data Center Operations – IT Data Center Administrator, DevOps Leaders, Heads of Digital Transformation/Innovation, and Experts in Cloud Computing from across India's industry verticals, all under one roof.

About Trescon

Trescon is a multinational business events and consulting company that offers a variety of business services to a clientele that is diverse and includes businesses, governments, and individuals. With the help of conferences, roadshows, expos, demand creation, investor connect, and advisory services. Trescon produces highly targeted B2B events that link companies with prospects. For more information visit: tresconglobal.com.

For further details about the announcement, please contact:
Nupur Aswani,
Head – Media, PR & Corporate Communications, Trescon
media@tresconglobal.com
+91 95559 15156

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Olympus EU-ME3 Ultrasound Processor, Delivers Higher Resolution Images for Endoscopic Ultrasound

TOKYO / HAMBURG, Oct 10, 2022 – (ACN Newswire) – Olympus Corporation (Olympus), a global medtech company committed to making lives healthier, safer and more fulfilling, has announced the launch of the EU-ME3, a new Endoscopic Ultrasound Processor which addresses the needs of healthcare professionals for high-quality clear images while conducting endoscopic ultrasound procedures. The EU-ME3 will be available in Europe, the Middle East, Africa, parts of Asia, and Oceania within this fiscal year.

Olympus announces the global launch of the EVIS EUS Endoscopic Ultrasound Center EU-ME3. [Image: Olympus Corp]
Olympus announces the global launch of the EVIS EUS / EU-ME3 Endoscopic Ultrasound Center [Image: Olympus Corp]

As a pioneer in endoscopic ultrasound (EUS) technology, Olympus aims to leverage its experience to enhance the care pathway in gastrointestinal and respiratory disease management. EUS technology is used in endoscopic ultrasonography, imaging to support the diagnosis of lesions in the pancreas, the bile ducts, or lesions that are located deep inside the body and are not visible with gastrointestinal endoscopes. In addition, the technology enables the detailed examination of pancreatitis, pancreatic cancer, and the diagnosis of cancer invasion in the stomach and the esophagus. It also plays a key role in facilitating the visualization of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) for early, minimally invasive diagnosis and lung cancer staging.

“It is said that pancreatic cancer is difficult to be detected in its early stages, and that lung cancer has the highest mortality rate among all cancers. With the launch of the EU-ME3, Olympus aims to enhance the standard of care including these diseases to further improve the quality of life of patients,” said Hironobu Kawano, Head of Endoscopic Solutions Division at Olympus.

Advancing the dimensions of Endosonography

With the needs of healthcare professionals and patient outcomes at its core, EU-ME3 can be tailored to improve a variety of procedures.

Enhanced visualization and usability

EU-ME3 provides outstanding image quality and functionality – the image quality has been substantially enhanced compared to the prior generation model (EU-ME2), providing enhanced visualization, and supporting more reliable diagnosis and treatment.

Shear Wave Quantification, a newly equipped feature for EU-ME3, also contributes to accurate diagnosis by providing quantitative information on the stiffness of tumor and inflamed lesions, an important factor when diagnosing the degree of pancreatitis and malignancy of pancreatic cancer during endoscopic ultrasonography.

Focus on procedure by tailoring

The EUS procedure typically utilizes a variety of observation modes depending on procedure type or clinical area. In addition to the basic observation mode, EU-ME3 offers software options for individual clinical needs, aimed at tailoring depending on specialty.

Smart and customizable user settings make it easy to fulfil needs for multiple specialties and personal requirements, while the backlit keyboard includes a simple, easy-to-use large touch panel and trackpad, designed to support better operability and easier cleaning.

With EU-ME3, the aim is seamless workflow integration for healthcaare professionals while advancing the dimensions of endosonography for better overall patient outcome.

About Olympus

In its Endoscopic Solutions business, Olympus uses innovative capabilities in medical technology, therapeutic intervention and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic and minimally invasive procedures to improve clinical outcomes, reduce overall costs and enhance the quality of life for patients. Starting with the world’s first gastrocamera in 1950, Olympus’ Endoscopic Solutions portfolio has grown to include endoscopes, laparoscopes, and video imaging systems, digital and integrated customer solutions, as well as solutions for infection prevention. For more information, visit www.olympus-global.com and follow our global Twitter account: @Olympus_Corp.

Media Contacts
Nao Tsukamoto – Global-Public_Relations@olympus.com
Jessica Lee – Jessica.yy.lee@fleishman.com

* Registered name: EVIS EUS ENDOSCOPIC ULTRASOUND CENTER OLYMPUS EU-ME3. EU-ME3 is manufactured by Olympus Medical Systems Corporation.
** Products or devices presented include technology which may be pending regional regulatory approval and are not available for sale in all regions.

Olympus Corp [TYO: 7733] [ADR: OCPNY] [GDR: OLYS] https://www.olympus-global.com



Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Hua Medicine’s Innovative First-In-Class Glucokinase Activator (GKA) HuaTangNing Is Approved, New Type 2 Diabetes Treatment Paradigm to Begin in China

SHANGHAI, CHINA, Oct 10, 2022 – (ACN Newswire) – Hua Medicine (the "Company", HKEx Stock Code: 2552.HK) today announces that the New Drug Application (NDA) of HuaTangNing (dorzagliatin tablets, HMS5552), a first-in-class glucokinase activator (GKA) developed by the Company has been approved by the National Medical Products Administration (NMPA) of China on October 8th for two indications, both to improve blood glucose control for Type 2 diabetes (T2D) patients, as monotherapy for drug-naive T2D patients, or in combination with metformin in metformin tolerated T2D patients to control blood glucose level. For those patients with chronic kidney disease (CKD) and Type 2 diabetes (i.e., diabetes kidney disease), no dose adjustment is required. At the same time, clinical trials have shown that HuaTangNing in combination with empagliflozin (SGLT-2 inhibitor) and sitagliptin (DPP-IV inhibitor) is expected to better improve blood glucose control and pancreatic islet functions in T2D patients than either empagliflozin or sitagliptin taken alone.

HuaTangNing is the first approved glucokinase activator (GKA) worldwide. Accordingly, the commercialization of HuaTangNing represents the first time globally in almost ten years that a new mechanism of action to treat Type 2 diabetes is introduced, and the first time in history that a global first-in-class drug for Type 2 diabetes is introduced first in China. This milestone represents unprecedented progress in the application of innovative scientific concepts in the Chinese biopharmaceutical industry to meet the clinical needs of Chinese patients. HuaTangNing is the first innovative first-in-class drug developed using the operation model of "Integration of global pharmaceutical research and development resources, to achieve joint innovation," and whereby China has led pharmaceutical innovation into a new historical stage.

With the mission of "For Patients, Global Innovation, Effective Medicines", Hua Medicine has independently developed HuaTangNing, a first-in-class drug based on the characteristics of Chinese diabetic patients. Since the beginning of its scientific development, the research and development project of HuaTangNing has been highly valued by the new drug R&D community and national drug regulators. The project was selected as a national key scientific and technological project during the "12th Five-Year Plan" and the "13th Five-Year Plan" periods. HuaTangNing is a drug with new concept, new mechanism, new efficacy, new structure and new technology. It is led by a Chinese R&D team and Chinese clinical researchers from pre-clinical to Phase I, II, and III clinical trials. Therefore, it is not only a major R&D breakthrough in translating innovative concepts into innovative products, but also a pioneering path for China in developing first-in-class drugs independently. The approval of HuaTangNing also represents the first approved GKA drug, after many large and small pharmaceutical companies globally have spent over 2 decades of R&D resources on the glucokinase activator class, thereby achieving a breakthrough from zero. Going forward, Hua Medicine will partner with Bayer, a leading global pharmaceutical company, to commercialize HuaTangNing in China, benefiting diabetic patients and their families.

Globally, the incidence of diabetes has been on the rise. According to the International Diabetes Federation (IDF), the number of adult diabetes patients worldwide reached 537 million in 2021, which was an increase of 74 million or 16% from 2019. Global health spending due to diabetes and its complications stood at USD 966 billion in 2021. China is no exception. There were over 140 million diabetic patients in 2021, 51.7% of which (around 72.83 million) have not been diagnosed or treated. In addition, fluctuating blood glucose levels lead to a series of diabetic complications such as cardiovascular and cerebrovascular, kidney, eye diseases, and diabetic feet, etc., which greatly affect the survival and life quality of diabetic patients, and exert a heavy pressure on their families. Therefore, stabilizing the T2D patient's blood glucose level at a good TIR (Time in Range) is an important goal in diabetes treatment and management. According to the 14th Five-Year National Health Planning issued by the General Office of the State Council, improving the prevention and treatment capacity of diabetes and other major chronic diseases is a key health-care topic for the country. It is estimated that over 65% of T2D patients will be covered by the health management service of community-level medical institutions during the 14th Five Year Plan period. The NDA approval and HuaTangNing adheres closely to the national strategy of developing the pharmaceutical industry and improving citizens' health.

A rapidly growing population of diabetic patients and a huge market for diabetes drugs clearly establish strong unmet medical needs. With the original concept of "repairing the sensor, restoring homeostasis, and treating the underlying cause of diabetes", Hua Medicine boldly aims at directly addressing the root cause of the failure of blood glucose sensors in T2D patients. Clinical studies have shown that HuaTangNing can restore the impaired glucokinase sensor function and improve the ability of T2D patients to regulate blood glucose autonomously, thus potentially control the progression and complications of Type 2 diabetes from its source.

As a new class of T2D treatment drug, the R&D of HuaTangNing has received continuous attention from the academic community worldwide. In 2018, the results of its Phase II clinical trial were published in The Lancet Diabetes and Endocrinology, a top international medical journal, which was the first time for the journal to publish the clinical research results of a T2D original innovative drug from China. In May 2022, Nature Medicine, a top international medical journal, simultaneously published two peer-reviewed papers on the results of our two Phase III clinical trials, describing the results of our monotherapy trial (the SEED study), and in combination with metformin trial (the DAWN study), respectively. It fully recognized HuaTangNing as a first-in-class diabetic drug with significant safety advantages and the characteristics of improving pancreatic islet functions in T2D patients. The unique advantages of HuaTangNing in T2D patients with nephropathy suggested by the clinical trials was also highlighted.

Other clinical research also showed that HuaTangNing safely creates clear synergies in combination therapy with DPP-4 inhibitors and SGLT-2 inhibitors in blood glucose control, suggesting its broader potential in T2D patients with different needs in glycemic control and at different stages of disease progression. By potentially restoring early-phase insulin secretion and improving beta-cell function, HuaTangNing is expected to be a key path in diabetes remission. In the future, Hua Medicine will continue to explore HuaTangNing's potential in the remission of T2D drug discontinuation and the combination therapies with the other nine existing types of diabetes drugs. Hua Medicine is committed to addressing the needs of diabetic prevention, remission and complication control, and bringing Chinese innovation to the world.

Xiaolan Zhou, Executive Vice President, Pharmaceuticals Division, Bayer AG and President of Bayer Pharmaceuticals China, said, "Bayer has been working on diabetes treatment and contributing to the development of diabetes prevention and treatment in China for years. HuaTangNing and Glucobay, the first oral hypoglycemic drug with impaired glucose tolerance (IGT), together with continuous glucose monitoring systems (CGMs), establish end-to-end course management from prevention to treatment for Chinese T2D patients. Real-time blood glucose monitoring helps achieve the goal of 'steady blood glucose control'. At the same time, Bayer proactively explores digital solutions to help hundreds of millions of Chinese patients to achieve the vision of diabetes-free."

Dr. Li Chen, the founder, CEO and Chief Scientific Officer of Hua Medicine, said, "the NDA approval of HuaTangNing is a major milestone for Hua Medicine, as it also marks that the innovative drug industry in China has entered a new stage of new development. Diabetes chronic disease management is strategically important for China's economy and people's livelihood. Hua Medicine adheres to our original intention of 'China leading pharmaceutical innovation'. Amid fierce international competition, researchers and partners of Hua Medicine have spent 10 years of hard work to develop the first-in-class new diabetes drug – first in the world and start from China, achieving a breakthrough from zero. This achievement is attributed to all Chinese scientists, clinicians and partners participated in the R&D of HuaTangNing. We are proud of HuaTangNing and grateful to everyone for their hard work and wholehearted dedication. At the same time, Hua Medicine looks forward to in-depth integration and full vitality with Bayer in the commercialization of HuaTangNing, which will bring new hope of diabetes prevention, treatment and relief to up to one hundred million Chinese T2D patients, establish standards for diabetes prevention and treatment, and contribute to the national strategy of achieving Healthy China 2030."

About HuaTangNing
HuaTangNing (dorzagliatin tablets) is a first-in-class glucokinase allosteric activator (GKA) with a brand-new mechanism. It can be used alone or in combination with metformin hydrochloride (when using metformin hydrochloride alone is ineffective in controlling blood glucose), to improve blood glucose control for T2D adult patients with diet and exercise. HuaTangNing targets at restoring the impaired glucose sensor glucokinase (GK) in pancreas, intestine and liver, to achieve one target with multiple points and coordinated blood glucose control. It regulates glucose stimulated secretion of the glycemic controlling hormones insulin, GLP-1 and glucagon in diabetes patients, which leads to the improvement of early-phase insulin secretion and disposition index. It has potential in restoring glucose homeostasis and diabetes remission. Results from two Phase III registered trials of HuaTangNing monotherapy and combination therapy with metformin in metformin tolerated T2D patients have shown that HuaTangNing significantly improves glycemic control with effective reduction of post prandial glucose, low risk of hypoglycemia, well tolerance and safety. HuaTangNing demonstrated a linear correlation between drug dose and plasma exposure, with high target organs distributed in pancreas, intestine and liver. It showed low renal excretion and similar pharmacokinetic profiles at End Stage Renal Disease (ESRD) patients and healthy subjects, which suggest it can be readily used in those patients with renal insufficiency without dose adjustment. The unique mechanism of action, desirable pharmacokinetic, and good safety and tolerability profile establish HuaTangNing as a differentiated new class of anti-diabetes therapy.

About Hua Medicine
Hua Medicine is an innovative drug development company found in China, focused on developing novel therapies for patients worldwide with unmet medical needs. Based on global resources, Hua Medicine teams up with global high-caliber people to develop breakthrough technologies and products, which contribute a global innovation in diabetes care. Targeting the glucose sensor, glucokinase, HuaTangNing (dorzagliatin tablets) as Hua Medicine's cornerstone product, restores glucose sensitivity in T2D patients and has completed registered SEED and DAWN Phase III trials in China. The NDA (New Drug Application) of HuaTangNing has been officially approved by the China National Medical Products Administration (NMPA). This first-in-class glucokinase activator has demonstrated its potential of achieving diabetes remission to help millions of diabetic patients around the world.

About Bayer
Bayer is a global enterprise with core competencies in health and agriculture of life science. Its products and services are designed to help human and the earth thrive by supporting the efforts to overcome major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable growth and having a positive impact on business. At the same time, Bayer aims to increase its profitability and create value through innovation and growth. Globally, the brand of Bayer stands for trust, reliability and quality. In the fiscal year of 2020, Bayer had around 100,000 employees, 41.4 billion euros of sales, and 4.9 billion euros of R&D expenses (excluding special programs). For more information, please visit www.bayer.com.

About the cooperation between Hua Medicine and Bayer
In August 2020, Bayer, a multinational pharmaceutical company, and Hua Medicine, a Chinese innovative drug research and development company, announced a strategic partnership on dorzagliatin, a first-in-class diabetes treatment drug, in China. This partnership aims at leveraging Bayer's prominent advantages in diabetes management in China and Hua Medicine's R&D expertise in diabetes treatment. Both parties are committed to benefiting hundreds of millions of China diabetic patients through new therapeutic options. Under the terms of the agreement, Hua Medicine as the market authorization holder (MAH) shall be responsible for clinical development, registration, product supply and distribution, while Bayer as the promotion service provider shall be responsible for marketing, promotion and medical education activities in China. The Pharmaceuticals China Innovation Center of Bayer facilitated this collaboration. As a global pharmaceutical leader, Bayer is committed to cooperating with external partners to promote breakthrough innovations, bring positive changes to patients, and achieve the goal of "cooperative innovation and joint cure".


Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com